A placa de hidrocoloide para prevenção de lesão por pressão na prona é efetiva? Análise de uma coorte retrospectiva

Abstract

The aim of this study was to evaluate the presence of pressure injuries and their association with the use of hydrocolloid plaque in patients admitted to the ICU-COVID, submitted to pronation. This is a retrospective cohort performed with patients admitted to two COVID-ICUs who pronated during hospitalization. Patients who did not have data regarding pronation or injury were excluded. Eighty patients were included, who performed an average of three pronations with an average stay of 19:48 hours. The hydrocolloid patch was used in 47.5% of the participants, with 43.8% applied in an extended area. Regarding the development of pressure injuries, 42.5% developed from one to six wounds on the prone, stage I or II (35.0%). A significant difference was observed between those who were female, had altered hemoglobin, presence of edema or fever in pronation (p<0.05). There was no significant difference between those who used or did not use a hydrocolloid patch. In logistic regression analyses, it was observed that, with each new pronation, patients have 1.3 times more chance of developing injury (p<0.05). The effectiveness of using a hydrocolloid patch in preventing pressure injuries in the prone position is still controversial. It is suggested that randomized controlled trials be carried out to verify its efficacy and cost-effectiveness.